InvestorsHub Logo

misiu143

11/18/16 11:33 AM

#7520 RE: Redyu #7517

FDA approved 30 patients for Phase 3 IV injection for TaiMed.
I think they needed to do the same for CYDY SC injection.
AIDS is a very serious disease , without good treatment so far , this is a reason , imo.

gestalt2

11/18/16 11:34 AM

#7521 RE: Redyu #7517

the FDA will approve the p3 adjunct trial with only 30 patients AND enough data for the safety part of the approval. The FDA has not said how many patients are needed for the safety aspect but it is assumed that it is more than 30. the P3 mono trial is 300 patients and if they can get enough safety data from the 300 patients earlier than the completion of the p3 mono trial then the p3 adjunct trial will have FDA approval.